mRNA |
BMS-345541 |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.09 |
mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.09 |
mRNA |
BRD1835 |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.09 |
mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
0.05 |
0.1 |
mRNA |
Zebularine |
CTRPv2 |
pan-cancer |
AAC |
0.059 |
0.1 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.1 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.1 |
mRNA |
ML334 diastereomer |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.1 |
mRNA |
GSK-J4 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
0.1 |
mRNA |
BRD-K94991378 |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.1 |